FBLN2 and meningioma: In conclusion, we show that Fibulin-2 is expressed at higher levels both at the protein and RNA level, in grade II meningiomas compared to grade I. This study demonstrates that elevated Fibulin-2 levels might be a novel grade II meningioma biomarker, when differentiating them from the grade I tumours.